References
- Fraser I S., Weisberg E. Injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust (special supplement) 1981; 1: 1
- Fraser I S. Abnormal uterine bleeding due to hormonal steroids and IUD's. Recent Advances in Fertility Regulation, C F. Chang, D Griffin, A Woolman. Atar S. A., Geneva 1981; 265
- Sivin I, Diaz S, Holma P, Alvarez-Sanchez F, Robertson D N. A four year clinical study of Norplant” implants. Stud Fam Plan 1983; 14: 184
- Gray R H. Patterns of bleeding associated with the use of steroidal contraceptives. Endometrial Bleeding and Steroidal Contraception, E Diczfalusy, I S. Fraser, F TG Webb. Pitman Press Bath. 1980; 14
- Fraser I S. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives. Contraception 1983; 28: 385
- World Health Organisation. Facts about an implantable contraceptive: memorandum from a W. H. O. meeting. Bull. World Health Org 1985, in press
- Holma P. Long term experience with Norplants contraceptive implants in Finland. Contraception 1985; 31: 231
- Koetsawang S. Present management of abnomal bleeding associated with steroidal contraceptives. Endometrial Bleeding and Steroidal Contraception, E Diczfalusy, I S. Fraser, F TG Webb. Pitman Press Bath. 1980; 50
- Fraser I S., Diczfalusy E. A perspective of steroidal contraception and abnormal bleeding: what are the prospects for improvement?. Endometrial Bleeding and Steroidal Contraception, E Diczfalusy, I S. Fraser, F TG Webb. Pitman Press Bath. 1980; 384
- Patterns and perceptions of menstruation, R Snowden, B Christian. Croom Helm, London 1983
- World Health Organisation. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects. Contraception 1978; 17: 395
- Fraser I S., McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984; 149: 788
- Nilsson C G., Holma P. Menstrual blood loss with contraceptive subdermal levonorgestrel implants. Fertil Steril 1981; 35: 304
- Short R V. The evolution of human reproductive. Proc Roy Soc B 1976; 195: 3
- Center for Disease Control Cancer and Steroid Hormone Study. Oral contraceptive use and the risk of ovarian cancer. JAMA 1983; 249: 1596
- Center for Disease Control Cancer and Steroid Hormone Study. Oral contraceptive use and risk of endometrial cancer. JAMA 1983; 249: 1600
- Weiner B, Johansson E DB. Contraception with d-nor-gestrel sillastic rods. Plasma levels of d-norgestrel and influence on ovarian function. Contraception 1976; 14: 551
- Maqueo M. Vascular and perivascular changes in the endometrium of women using steroidal contraceptives. Endometrial Bleeding and Steroidal Contraception, E Diczfalusy, I S. Fraser, F TG Webb. Pitman Press Bath. 1980; 138
- Population Reports: Injectables and Implants. Population Information Program. Series K, No. 1, Georg Washington University Medical Center, Washington, DC March, 1975
- El-Habashy M A., Mishell D R., Moyer D L. Effects of supplementary oral oestrogen on long acting injectable progestogen contraception. Obstet Gynecol 1970; 35: 51
- Johannisson E, Landgren B M., Diczfalusy E. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μ norethisterone mini-pill. Contraception 1982; 25: 13
- Tseng L, Gurpide E. Effects of progestins on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab 1975; 41: 402
- Rail M J., Soto-Lerreira G, Hanssens K Y. Effect of medroxyprogesterone acetate contraception on cytoplasmic estrogen receptor content of the human cervix uteri. Int J Fertil 1978; 23: 51
- Howard G, Elder M G., Fotherby K. Hormones in vascular disease, R M. Greenhalgh. Pitman Medical, London 1981; 294